Which medication is predominantly used for management of acute asthma attacks?

Albuterol is the predominant medication used for managing acute asthma attacks because it is a fast-acting bronchodilator that belongs to the class of medications known as short-acting beta-2 adrenergic agonists (SABAs). When administered, albuterol works by relaxing the muscles of the airways, leading to dilation and improved airflow to the lungs. This rapid action makes albuterol especially effective in providing immediate relief from the symptoms of an acute asthma attack, such as wheezing, shortness of breath, and chest tightness.

In contrast, fluticasone is an inhaled corticosteroid primarily used for long-term control and prevention of asthma symptoms rather than for acute attacks. It reduces inflammation in the airways but does not act quickly enough to alleviate sudden symptoms. Levalbuterol is another SABA, similar to albuterol, but it is less commonly used and often reserved for patients who may experience side effects from albuterol. Maintena, on the other hand, is an injectable medication used for the treatment of schizophrenia and is not indicated for asthma management. Hence, albuterol remains the first-line medication for acute asthma emergencies due to its speed and efficacy in bronchial dilation.